March 17, 2026
TOPLINE: Healthcare workers undergoing patch testing were more likely than nonhealthcare workers to have occupational skin disease (OSD) and hand dermatitis, with common allergens linked to […]
March 16, 2026
A new Janus kinase inhibitor medication, deuruxolitinib (Leqselvi, Sun Pharma UK Limited), has been approved in the UK for the treatment of severe alopecia areata in […]
March 13, 2026
If the experts behind the newly formed Lancet Commission on Skin Health have their way, the sun will never set on effective, efficient, and equitable dermatologic […]
March 13, 2026
A mother’s intuition and scientific eye sparked the discovery of a possible mechanism for infant eczema. The new findings, published in Nature, show that skin dendritic […]
March 12, 2026
TOPLINE: A meta-analysis of 41 studies found that parallel ridge and multicomponent patterns were the most significant dermoscopic features associated with acral lentiginous melanoma (ALM), whereas […]
March 12, 2026
TOPLINE: In a large population-based study, patients with vitiligo faced a substantial burden of affective and stress-related mental health disorders (MHDs). The morbidity profile largely resembled […]
March 11, 2026
TOPLINE: In a Danish cohort study, patients with hidradenitis suppurativa (HS) showed more than double the risk for self-harm and suicide than matched control individuals. METHODOLOGY: […]
March 10, 2026
Advanced practice clinicians (APCs) appear to be prescribing specialty dermatology medications at a faster rate of growth than physicians, a small new study showed. Edward I. […]
March 9, 2026
* The patients treated with the drug, tilrekimig, saw asignificant reduction in symptoms after 16 weeks and the drugwas well tolerated with a favorable safety profile […]